SecSonar.com

IM Cannabis Corp. (IMCC)

IM Cannabis Corp. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

IM Cannabis Corp. (IMCC) is a Drug Manufacturers - Specialty & Generic company based in IL with a market capitalization of $1M. Revenue grew 1.3% year-over-year and the company generated $3.3M in free cash flow. This page tracks IMCC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

IL · 95 employees · IPO May 20, 2020

Valuation

Valuation & price

$0.28 · as of May 26, 2026 · -92.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$3.55$1.85$0.14Jul 25Dec 25Jul 26Jul 7, 25$3.30Jul 9, 25$3.55Jul 11, 25$2.91Jul 15, 25$3.11Jul 17, 25$3.34Jul 21, 25$3.04Jul 23, 25$3.02Jul 25, 25$2.81Jul 29, 25$2.67Jul 31, 25$2.62Aug 4, 25$2.63Aug 6, 25$2.51Aug 11, 25$2.93Aug 13, 25$2.57Aug 15, 25$2.66Aug 19, 25$2.53Aug 21, 25$2.18Aug 25, 25$2.30Aug 27, 25$2.26Aug 29, 25$2.32Sep 3, 25$2.04Sep 5, 25$1.97Sep 9, 25$1.79Sep 11, 25$2.01Sep 16, 25$1.96Sep 18, 25$1.97Sep 22, 25$1.93Sep 24, 25$1.84Sep 26, 25$1.77Sep 30, 25$1.92Oct 2, 25$1.92Oct 6, 25$2.07Oct 8, 25$2.00Oct 10, 25$1.93Oct 14, 25$1.95Oct 16, 25$1.91Oct 21, 25$1.96Oct 23, 25$1.68Oct 27, 25$1.43Oct 29, 25$1.41Oct 31, 25$1.44Nov 4, 25$1.28Nov 6, 25$1.32Nov 10, 25$1.42Nov 12, 25$1.44Nov 14, 25$1.24Nov 18, 25$1.34Nov 20, 25$1.38Nov 25, 25$1.58Nov 28, 25$1.82Dec 2, 25$1.75Dec 4, 25$1.79Dec 8, 25$1.55Dec 10, 25$1.68Dec 12, 25$1.88Dec 16, 25$1.73Dec 18, 25$1.52Dec 22, 25$1.51Dec 24, 25$1.48Dec 29, 25$1.38Jan 2, 26$1.49Jan 6, 26$1.47Jan 8, 26$1.44Jan 12, 26$1.39Jan 14, 26$1.42Jan 16, 26$1.38Jan 21, 26$1.38Jan 23, 26$1.35Jan 27, 26$1.36Jan 29, 26$1.35Feb 2, 26$1.28Feb 4, 26$1.19Feb 9, 26$1.14Feb 11, 26$1.18Feb 13, 26$1.09Feb 18, 26$1.01Feb 20, 26$0.95Feb 24, 26$0.80Feb 26, 26$0.72Mar 2, 26$0.72Mar 4, 26$0.70Mar 6, 26$0.75Mar 10, 26$0.81Mar 12, 26$0.92Mar 17, 26$0.58Mar 19, 26$0.65Mar 23, 26$0.65Mar 25, 26$0.59Mar 27, 26$0.51Mar 31, 26$0.37Apr 2, 26$0.34Apr 7, 26$0.35Apr 9, 26$0.35Apr 13, 26$0.38Apr 15, 26$0.38Apr 17, 26$0.38Apr 22, 26$0.34Apr 24, 26$0.28Apr 28, 26$0.26Apr 30, 26$0.28May 4, 26$0.28May 6, 26$0.26May 8, 26$0.24May 12, 26$0.25May 14, 26$0.24May 18, 26$0.23May 20, 26$0.24May 22, 26$0.24May 28, 26$0.29Jun 1, 26$0.32Jun 3, 26$0.29Jun 5, 26$0.27Jun 9, 26$0.25Jun 11, 26$0.25Jun 15, 26$0.26Jun 17, 26$0.22Jun 22, 26$0.18Jun 24, 26$0.16Jun 26, 26$0.14Jul 2, 26$0.15
$0.1452-week range$3.55
Loading valuation history…

Fundamentals

Key fundamentals

$1M

Market cap

1.3%

Revenue growth (YoY)

17.7%

Gross margin

$3.3M

Free cash flow (USD)

$13.5M

Net debt

80.5%

Share dilution

0/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2017 → 2025

FY 2017$0.00FY 2018$4.4MFY 2019$9.1MFY 2020$15.9MFY 2021$34.1MFY 2022$54.3MFY 2023$48.8MFY 2024$54.0MFY 2025$54.7M
$0$54.7M

Free cash flow by year

2017 → 2025

FY 2017$0.00FY 2018$-522.1KFY 2019$-775.3KFY 2020$-10.6MFY 2021$-39.0MFY 2022$-14.2MFY 2023$-8.7MFY 2024$-1.2MFY 2025$4.7M
$0$4.7M

Gross margin by year

2021 → 2025

FY 202118.6%FY 202216.9%FY 202320.2%FY 202415.6%FY 202517.7%
18.6%17.7%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingNote Purchase AgreementJul 1, 2026Filing
  • 6-K filingLetter of Intent for SaleJun 18, 2026Filing
  • 6-K filingResale Registration Statement FilingJun 9, 2026Filing
  • 6-K filingConvertible Note AgreementJun 3, 2026Filing
  • Annual reportAnnual Report FiledMay 13, 2026Filing
  • 6-K filingConvertible Note AgreementMay 7, 2026Filing
  • 6-K filingRegulatory UpdateApr 10, 2026Filing
  • 6-K filingNote Purchase AgreementApr 6, 2026Filing
  • Annual reportAnnual Report FiledMar 31, 2026Filing

Questions

Frequently asked questions

What is IM Cannabis Corp.'s market cap?

IM Cannabis Corp. (IMCC) has a market capitalization of $1M.

What is IMCC's P/E ratio?

A meaningful P/E ratio is not available for IMCC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying IMCC stock?

SEC Form 4 filings show no open-market insider buys at IM Cannabis Corp. in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - Specialty & Generic

SXTC

China SXT Pharmaceuticals, Inc.

$1.3M

AKAN

Akanda Corp.

$706.9K

SBFM

Sunshine Biopharma, Inc.

$1.4M

PRPH

ProPhase Labs, Inc.

$457.1K

PRFX

PRF Technologies Ltd.

$368K

UPC

Universe Pharmaceuticals Inc.

$1.8M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.